NHN Becomes a Hub of Medical Excellence

Two directors of Square Pharmaceuticals, Samuel S Chowdhury and Ratna Patra, each purchased 15 lakh shares, totaling Tk 64.58 crore, based on the DSE’s disclosed closing price of Tk 215.40 per share. These transactions, declared earlier in March, reflect continued confidence in the company, whose shares rose 0.05% during morning trading.

The cost of DWASA’s 'Dhaka Environmentally Sustainable Water Supply Project' has surged by Tk 28.28 billion in its third revision, raising the total estimated budget to Tk 109.75 billion—126.38% higher than the original Tk 48.48 billion approved in 2013. Despite an 11-year delay and 87% physical progress, the project remains incomplete.

Bangladesh’s Chief Adviser, Professor Muhammad Yunus, has requested China to develop a 50-year masterplan for managing the country’s complex river and water systems, which are vital to its ecosystem but also pose significant challenges.

The High Court (HC) has canceled its previous order to appoint a receiver for managing Beximco Group companies, allowing them to operate under their own management while being supervised by Bangladesh Bank and other regulatory bodies.

Ratna Patra, vice chairman and sponsor of Square Pharmaceuticals, announced her plan to purchase 15 lakh shares worth approximately Tk 33 crore at the current market price. The purchase will take place within the next 30 working days through both public and block markets on the Dhaka Stock Exchange (DSE).

The National Board of Revenue (NBR) has exempted the advance tax (AT) on the import of raw materials for cancer drug manufacturing, aiming to reduce production costs and drug prices. Previously, a 5% AT was imposed, but it has now been reduced to 2% or eliminated altogether.